United States · FDA National Drug Code directory

PREDNISONE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
87063-043_4a1001c0-0013-e6a5-e063-6294a90af48e
Product NDC
87063-043
Form
TABLET
Composition / generic term
PREDNISONE
Labeler
ASCLEMED USA INC.
Marketing category
ANDA
Marketing start / end (source format)
20220328
Source listing expiry
20271231

Source-listed ingredients

  • PREDNISONE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (87063-043-01) · 87063-043-01
  • 18 TABLET in 1 BOTTLE (87063-043-18) · 87063-043-18
  • 20 TABLET in 1 BOTTLE (87063-043-20) · 87063-043-20
  • 21 TABLET in 1 BOTTLE (87063-043-21) · 87063-043-21
  • 30 TABLET in 1 BOTTLE (87063-043-30) · 87063-043-30
  • 60 TABLET in 1 BOTTLE (87063-043-60) · 87063-043-60
  • 10 BLISTER PACK in 1 CARTON (87063-043-78) / 10 TABLET in 1 BLISTER PACK · 87063-043-78
  • 90 TABLET in 1 BOTTLE (87063-043-90) · 87063-043-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →